|
|
|
|
Awards recognize companies that have done the best work in strategic M&A in three sectors: media,pharma/biotech and information technology
NEW YORK, N.Y. - November 19, 2009 - The Deal LLC, (www.TheDeal.com), the media and information company for the deal economy, today announces the winners of the inaugural Most Admired Corporate Dealmakers Awards. Winners were selected in three industry sectors in a survey of The Deal's readers, conducted by Applied Research-West, based upon their excellence in conceiving and executing transactions worldwide.
Companies recognized for making the most effective use of transactional tools include Walt Disney Co. in media, Abbott Laboratories in pharma/biotech and Microsoft Corp. in information technology. Runner-ups include CBS Corp. in media, Johnson & Johnson in pharma/biotech and Cisco Systems Inc. in information technology.
Award winners were recognized today at a luncheon ceremony co-hosted by Kenneth Klee, corporate dealmaker editor at The Deal and Alexis Glick, anchor and vice president of business news at FOX Business News.
"These survey results confirm the degree to which M&A has come of age as a strategic tool," said Kenneth Klee, corporate dealmaker editor at The Deal. "All these companies have helped elevate the state of the art in strategic transactions, and our readers have recognized that."
Companies considered for the awards survey were those with a market capitalization of $5 billion or more as of June 30, 2009 or, in the case of media, a market cap of $1 billion on that date. The Deal, along with data partner Capital IQ, the leader in web-based professional financial information services, then screened for the companies in each sector that closed the highest number and dollar value of acquisitions and divestitures in the past three and a half years. The selection formula also recognized companies for doing a high dollar volume of deals compared to their market capitalizations on the start date.
After the initial pool of candidates was determined by Capital IQ, editors at The Deal reviewed each company's transaction lists and checked them against The Deal Pipeline, (www.thedeal.com/pipeline), a deal discovery and sourcing database, to narrow the list to thirty major companies.
The Deal's readers--transaction-focused corporate executives, financiers, investors and advisers--then determined the winners. With the assistance of survey partner, Applied Research-West readers were asked to rate each company on four criteria: choice of targets and strategy; price paid (or received) compared to value; execution, including integration; and overall quality of the deal team.
An article detailing the Most Admired Corporate Dealmakers study, along with data on the deals done by the candidate companies, appeared in the September 21-October 4, 2009 issue of The Deal magazine, and online at http://www.thedeal.com/corporatedealmaker/mostadmired. A second article, announcing and profiling the winners, will be published in both The Deal and online, on November 30.
About The Deal LLC
The Deal LLC, (www.thedeal.com), is a diversified media company that is the authoritative voice of the deal economy. We serve the global deal community--corporate and financial dealmakers, advisers and institutional investors--by providing business and financial news and information that offers fresh insights on the deal economy, a set of interrelated activities, focused on dealmaking of all kinds, whose purpose is to generate corporate growth in a continually changing global market. We offer a comprehensive line of print and electronic products--The Deal Pipeline, The Deal, The Daily Deal and TheDeal.com--along with live annual events like The Deal Economy conference. The Deal LLC, a privately held company, is owned by private investment funds sponsored by Wasserstein & Co. LP.
About Standard & Poor's Capital IQ
Capital IQ, a Standard & Poor's business, delivers comprehensive fundamental and quantitative research and analysis solutions to over 4,200 investment management firms, investment banks, private equity funds, advisory firms, corporations, and universities worldwide. Its solutions are based on the Capital IQ Platform, Compustat, ClariFI, and SystematIQ products, and offer an array of powerful applications for desktop research, screening, real-time market data, backtesting, portfolio management, financial modeling, and quantitative analysis. For more information, please visit Capital IQ's web site at www.capitaliq.com.
